A Phase 1 and Biodistribution Study of ABT-806i, an In-111-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806

Gan, HK; Burge, M; Solomon, B; Lee, ST; Holen, KD; Zhang, YM; Ciprotti, M; Lee, FT; Munasinghe, W; Fischer, J; Ansell, P; Fox, G; Xiong, H; Reilly, EB; Humerickhouse, R; Scott, AM

Gan, HK (corresponding author), Austin Hosp, Canc Clin Trial Ctr, 145 Studley Rd, Heidelberg, Vic 3084, Australia.

JOURNAL OF NUCLEAR MEDICINE, 2021; 62 (6): 787

Abstract

ABT-806 is a tumor-specific antibody targeting the epidermal growth factor receptor (EGFR). This study assessed safety, biodistribution, and pharmacok......

Full Text Link